PRESENTATION

Q2 FY2021 — Presentation

Q2 FY2021PDF · 16 pages603 KB
CACI International Inc
Q2 FY21 Earnings Conference Call
January 28, 2021
CACI Proprietary Information

-- 1 of 16 --

2 CACI Q2 FY21 Earnings Conference Call
There are statements made herein that do not address historical facts and, therefore, could be interpreted to be forward-
looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject
to risk factors that could cause actual results to be materially different from anticipated results. These risk factors include, but
are not limited to, the following: our reliance on U.S. government contracts, which includes general risk around the government
contract procurement process (such as bid protest, small business set asides, loss of work due to organizational conflicts of
interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in
U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget
priorities, such as for homeland security or to address global pandemics like COVID-19; legal, regulatory, and political change
from successive presidential administrations that could result in economic uncertainty; changes in U.S. federal agencies, current
agreements with other nations, foreign events, or any other events which may affect the global economy, including the impact
of global pandemics like COVID-19; the results of government audits and reviews conducted by the Defense Contract Audit
Agency, the Defense Contract Management Agency, or other governmental entities with cognizant oversight; competitive
factors such as pricing pressures and/or competition to hire and retain employees (particularly those with security clearances);
failure to achieve contract awards in connection with re-competes for present business and/or competition for new business;
regional and national economic conditions in the United States and globally, including but not limited to: terrorist activities or
war, changes in interest rates, currency fluctuations, significant fluctuations in the equity markets, and market speculation
regarding our continued independence; our ability to meet contractual performance obligations, including technologically
complex obligations dependent on factors not wholly within our control; limited access to certain facilities required for us to
perform our work, including during a global pandemic like COVID-19; changes in tax law, the interpretation of associated rules
and regulations, or any other events impacting our effective tax rate; changes in technology; the potential impact of the
announcement or consummation of a proposed transaction and our ability to successfully integrate the operations of our
recent and any future acquisitions; our ability to achieve the objectives of near term or long-term business plans; the effects of
health epidemics, pandemics and similar outbreaks may have material adverse effects on our business, financial position, results
of operations and/or cash flows; and other risks described in our Securities and Exchange Commission filings.
Forward-looking Statements

-- 2 of 16 --

3 CACI Q2 FY21 Earnings Conference Call
On Today’s Call
John Mengucci
President and Chief
Executive Officer
Thomas Mutryn
Chief Financial Officer
Greg Bradford
President and Chief
Executive, CACI Limited UK

-- 3 of 16 --

4 CACI Q2 FY21 Earnings Conference Call
We honor Jack’s
visionary leadership
for nearly half a century.
Dr. J.P. (Jack) London
1937 - 2021

-- 4 of 16 --

5 CACI Q2 FY21 Earnings Conference Call
Revenue +5.2% as reported, +4.3% organic
• Technology revenue +12.7%
Adjusted EBITDA Margin 11.9%1
Net Income and Diluted EPS +34%
Robust cash flow from operations ($190 million)1
Q2 Results – Another Strong Quarter
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.

-- 5 of 16 --

6 CACI Q2 FY21 Earnings Conference Call
Q2 awards $2.1B (book-to-bill 1.4x; 1.5x TTM), with several expanded renewals
$447 million contract supporting acquisition Mission Technology
− Contract consolidates with us work previously performed by six competitors
$376 million Technology contract for a web-based supply chain system
− Expanded scope to include Cloud migration, SAP HANA work, and business modernization
$160 million AFCENT NOSC contract to provide Enterprise Technology to the
U.S. Air Force
− Expanded scope to deliver additional network and cyber innovations, supporting
higher margins
Strong Recompete Performance and Expansion

-- 6 of 16 --

7 CACI Q2 FY21 Earnings Conference Call
Investments drive higher value for customers and IP, differentiation, and
future growth for CACI
CACI is on the forefront of laser communication technology in the Space domain
Long distances, faster, with lower probability of detection/defeat by adversaries
Currently developing laser communications systems for a half dozen space
programs – Earth orbit and deep-space, manned and unmanned
Our technology has dramatically lower size, weight, and power (SWAP)
characteristics, positioning CACI for a wide range of large Space opportunities
Our technologies can also be used for terrestrial applications, including
secure communications initiatives
Investing Ahead of Customer Need

-- 7 of 16 --

8 CACI Q2 FY21 Earnings Conference Call
Large and growing addressable market of >$230 billion
Bipartisan support for defense and national security priorities
Global threat environment remains elevated
Government fiscal year 2021 now fully funded – within the budget, we see benefits
for our Counter-UAS, cyber, defense health, and Navy engineering work
Continue to see IT modernization initiatives as high priority due to dispersed
operating models due to COVID-19, as well as other recent events
CACI well aligned to critical, well-funded budget priorities
Budget and Market Environment

-- 8 of 16 --

9 CACI Q2 FY21 Earnings Conference Call
Q2 FY21 Revenue and Net Income
$79
$106
$0
$20
$40
$60
$80
$100
$120
Q2 FY20 Q2 FY21
Net Income (Ms)
$1,395 $1,469
$800
$1,000
$1,200
$1,400
$1,600
Q2 FY20 Q2 FY21
Revenue (Ms) Revenue driven by new business wins,
on-contract growth, and acquired revenue
Organic growth of 4.3%
Technology revenue +12.7%,
Expertise revenue -1.3%
Higher net income driven by higher revenue,
favorable fixed-price contract performance,
and lower indirect costs and interest expense,
partially offset by higher tax rate
Adjusted EBITDA Margin of 11.9%1
Diluted EPS +34%
+5%
+34%
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.

-- 9 of 16 --

10 CACI Q2 FY21 Earnings Conference Call
▪ Q2 FY21 net cash provided by operating
activities excluding MARPA of
$190 million1, up 62% YoY
▪ Days Sales Outstanding of 53 days1
▪ Leverage of 2.0x2
▪ Strong cash flow and borrowing
capacity provides ample capital for
continued investment and available
liquidity for unforeseen events
Strong Cash Flow
$0
$50
$100
$150
$200
$250
$300
$350
$400
$450
$500
$550
$600
$650
$700
Cash Flow1 and CapEx
(millions, TTM)
Cash Flow from Operations excl. MARPA Capital Expenditures (CapEx)
1 Excludes CACI’s Master Accounts Receivable Purchase Agreement (MARPA); See slides at the end of this presentation for
definitions and reconciliations of non-GAAP measures.
2 Net debt to trailing-twelve-months (TTM) Adjusted EBITDA as of December 31, 2020.
1

-- 10 of 16 --

11 CACI Q2 FY21 Earnings Conference Call
Reaffirming FY21 Guidance
(1) See slides at the end of this presentation for additional information.
This guidance represents CACI views as of January 27, 2021. Investors are
reminded that actual results may differ from these estimates for reasons
described in the Company’s Safe Harbor Statement and filings with the SEC.
Organic revenue growth of
about 6.3% at the midpoint
Adj. EBITDA Margin1 of ~10.8%
Diluted shares outstanding
expected to be 25.7 million
Capital expenditures of
~$70 million
Guidance
Revenue
(millions) $6,050 – $6,250
Net Income
(millions) $372 – $392
Diluted EPS $14.47 – $15.25
Operating Cash Flow1
(millions) At least $600

-- 11 of 16 --

12 CACI Q2 FY21 Earnings Conference Call
Positive Forward Indicators for FY21
95%
Existing Business
STRONG
Performance
2%
Recompetes
HIGH
Win Rate
3%
New Business
QUALITY
Pipeline
Q2 FY21 contract awards of $2.1 billion
TTM Book-to-Bill of 1.5x
Record backlog of $22 billion,
+10% YoY
Pipeline of submitted bids totals
$7.1 billion
>70% for new business to CACI
and >50% Technology
Bids expected to be submitted in the
next two quarters total $13.0 billion
>70% for new business to CACI
and 50% Technology

-- 12 of 16 --

13 CACI Q2 FY21 Earnings Conference Call
Strong 1H FY21 performance while successfully navigating COVID-19
FY21 guidance reflects healthy organic growth, strong margin expansion,
and robust cash flow
CACI positioned well, performing well, and delivering on commitments
Confident in our ability to continue to deliver value to customers and shareholders
Talented employees committed to delivering Expertise and innovative
Technology in support of customers’ national security and modernization priorities
Delivering Results and Meeting Commitments

-- 13 of 16 --

14 CACI Q2 FY21 Earnings Conference Call
The Company defines net cash provided by operating activities excluding CACI’s Master Accounts Receivable Purchase
Agreement (MARPA) as net cash provided by operating activities calculated in accordance with GAAP, adjusted to exclude net
cash received from CACI’s MARPA for the sale of certain designated eligible U.S. government receivables. Under the MARPA,
the Company can sell eligible receivables, including certain billed and unbilled receivables up to a maximum amount of $200.0
million. The Company provides net cash provided by operating activities excluding MARPA to allow investors to more easily
compare current period results to prior period results and to results of our peers.
The Company views Adjusted EBITDA and Adjusted EBITDA margin, both of which are defined as non-GAAP measures, as
important indicators of performance, consistent with the manner in which management measures and forecasts the
Company’s performance. Adjusted EBITDA is a commonly used non-GAAP measure when comparing our results with those of
other companies. We define Adjusted EBITDA as GAAP net income plus net interest expense, income taxes, depreciation and
amortization expense, including depreciation within direct costs, and earnout adjustments. We consider Adjusted EBITDA to
be a useful metric for management and investors to evaluate and compare the ongoing operating performance of our
business on a consistent basis across reporting periods, as it eliminates the effect of non-cash items such as depreciation of
tangible assets, amortization of intangible assets primarily recognized in business combinations, as well as the effect of
earnout gains and losses, which we do not believe are indicative of our core operating performance. Adjusted EBITDA margin
is adjusted EBITDA divided by revenue.
These non-GAAP measures should not be considered in isolation or as a substitute for performance measures prepared in
accordance with GAAP.
Definitions of Non-GAAP Measures

-- 14 of 16 --

15 CACI Q2 FY21 Earnings Conference Call
Reconciliation of Net Cash Provided by Operating Activities to Net
Cash Provided by Operating Activities Excluding MARPA
These non-GAAP measures should not be considered in isolation or as a substitute for performance measures prepared in accordance with GAAP.
Three Months
Ended
Three Months
Ended
(dollars in thousands) 	12/31/2020 	12/31/2019
Net cash provided by operating activities 	205,387	$ 	133,821	$
Cash used (provided) by MARPA 	(15,553) 	(16,334)
Net cash provided by operating activities excluding MARPA 	189,834	$ 	117,487	$

-- 15 of 16 --

16 CACI Q2 FY21 Earnings Conference Call
Adjusted Earnings Before Interest, Taxes, Depreciation and
Amortization (Adjusted EBITDA)
These non-GAAP measures should not be considered in isolation or as a substitute for performance measures prepared in accordance with GAAP.
(dollars in thousands) 	12/31/2020 	12/31/2019 % Change
Net income 	106,478	$ 	79,195	$ 	34.5%
Plus:
Income taxes 	25,974 	16,278 	59.6%
Interest income and expense, net 	9,087 	14,714 	-38.2%
Depreciation and amortization expense,
including amounts within direct costs
33,041 	28,615 	15.5%
Earnout adjustments 	- 	2,100 	-100.0%
Adjusted EBITDA 	174,580	$ 	140,902	$ 	23.9%
(dollars in thousands) 	12/31/2020 	12/31/2019 % Change
Revenue, as reported 	1,468,711	$ 	1,395,469	$ 	5.2%
Adjusted EBITDA 	174,580 	140,902 	23.9%
Adjusted EBITDA margin 	11.9% 	10.1%
Three Months Ended
Three Months Ended

-- 16 of 16 --